Notably, the copy numbers of cancer-associated genes such as KRAS, ETV1, and SMAD2, displayed a subtype-specific increase in prevalence and magnitude along PDAC progression, highlighting the importance of matched primary and metastatic samples for uncovering such patterns. This evidence concerns the gene SMAD2 and cancer.